IX-01

DRUG4 trials

Sponsors

Ixchelsis Limited

Conditions

Healthy ParticipantsHealthy VolunteersPremature Ejaculation

Phase 1

A Study of Multiple Oral Doses of IX-01 in Healthy Men

CompletedNCT01994083

Ixchelsis LimitedHealthy Participants

Start: 2013-11-30End: 2014-03-31Updated: 2014-09-03

Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men

CompletedNCT02139826

Ixchelsis LimitedHealthy Participants

Start: 2014-05-31End: 2014-06-30Updated: 2020-08-20

A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects

CompletedNCT02792647

Ixchelsis LimitedHealthy Volunteers

Start: 2016-05-31End: 2016-10-31Updated: 2016-11-10

Phase 2

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

CompletedNCT02232425

Ixchelsis LimitedPremature Ejaculation

Start: 2014-09-30End: 2015-10-31Updated: 2020-08-17

Related Papers

PD69-01 A PHASE IIA STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF THE SELECTIVE OXYTOCIN RECEPTOR ANTAGONIST, IX-01, IN MEN WITH LIFELONG PREMATURE EJACULATION

The Journal of Urology2017-04-017 citations